Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

Todd Neale

December 04, 2024

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

Todd Neale

August 18, 2022

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

Meta分析：达比加群与华法林在房颤、静脉血栓栓塞患者中出血治疗效果比较

L.A. McKeown

January 27, 2014

News Daily News

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

L.A. McKeown

January 27, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Jason Kahn

October 04, 2013

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

Advertisement

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

VTE Risk Higher With COVID-19 Than With Flu

Study Affirms Thrombotic Risk in COVID-19

肺栓塞发作后，二级抗凝效果未持续

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

Meta分析：达比加群与华法林在房颤、静脉血栓栓塞患者中出血治疗效果比较

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content